Figure S3. Survival analysis based on Risk Score at diagnosis. Kaplan-Meier cancer specific survival analysis (pCSS) in 114 ccRCC patients in relation to (A) Wei Risk Score at diagnosis (B) a combination of Wei Risk Score and presence of distant metastasis at diagnosis. (C) Cumulative incidence of progress (CIP) analysis in 86 non-metastatic (M0) ccRCC patients in relation to Wei Risk Score at diagnosis. Log-rank p-values are presented. (PDF 79 kb
Table S2.Hazard ratios for OS and PFS based on CCR7 in different subgroups (High vs Low). (DOCX 63Â ...
Table S1.Univariate analyses of characteristics associated with overall survival and progression fre...
Figure S1. Sensitivity analysis of the association between TN and CSS outcomes in RCC patients. (TIF...
Table S4. Cox’s proportional hazard regression analysis for cancer specific survival (CSS) in 115 cc...
Table S5. Cox’s proportional hazard regression analysis for progress free survival (PFS) in 87 M0 cc...
Table S7. Cox’s proportional hazard regression analysis for progress free survival (PFS) in 87 M0 cc...
Table S2. Comparison of CNV results gained from HumanMethylation450K and HumanCytoSNP-12 arrays in 5...
Figure S2. Copy number variation (CNV) analysis. CNV analysis of twelve chromosome regions previousl...
Figure S4. Distribution of hyper- and hypomethylated CpGs in patients with or without specific genom...
Table S6. Clinicopathological parameters for tumors included in the heterogeneity analysis. (PDF 65 ...
Figure S5. Correlations between number of hypomethylated CpGs and number of genetic aberrations and ...
Figure S1. Single nucleotide polymorphism (SNP) analysis. SNP analysis of 65 genotyping probes on th...
Table S8. Top 20 most significant GO Terms for GeneIDs either hyper- or hypomethylated in M0-P and M...
Additional file 1: Figure S1. The relationship between DDR mutation and clinical outcome in the TCGA...
Figure S2.ROC analysis of Heng’s risk model alone and expanded with CCR7 continuous IOD score on pat...
Table S2.Hazard ratios for OS and PFS based on CCR7 in different subgroups (High vs Low). (DOCX 63Â ...
Table S1.Univariate analyses of characteristics associated with overall survival and progression fre...
Figure S1. Sensitivity analysis of the association between TN and CSS outcomes in RCC patients. (TIF...
Table S4. Cox’s proportional hazard regression analysis for cancer specific survival (CSS) in 115 cc...
Table S5. Cox’s proportional hazard regression analysis for progress free survival (PFS) in 87 M0 cc...
Table S7. Cox’s proportional hazard regression analysis for progress free survival (PFS) in 87 M0 cc...
Table S2. Comparison of CNV results gained from HumanMethylation450K and HumanCytoSNP-12 arrays in 5...
Figure S2. Copy number variation (CNV) analysis. CNV analysis of twelve chromosome regions previousl...
Figure S4. Distribution of hyper- and hypomethylated CpGs in patients with or without specific genom...
Table S6. Clinicopathological parameters for tumors included in the heterogeneity analysis. (PDF 65 ...
Figure S5. Correlations between number of hypomethylated CpGs and number of genetic aberrations and ...
Figure S1. Single nucleotide polymorphism (SNP) analysis. SNP analysis of 65 genotyping probes on th...
Table S8. Top 20 most significant GO Terms for GeneIDs either hyper- or hypomethylated in M0-P and M...
Additional file 1: Figure S1. The relationship between DDR mutation and clinical outcome in the TCGA...
Figure S2.ROC analysis of Heng’s risk model alone and expanded with CCR7 continuous IOD score on pat...
Table S2.Hazard ratios for OS and PFS based on CCR7 in different subgroups (High vs Low). (DOCX 63Â ...
Table S1.Univariate analyses of characteristics associated with overall survival and progression fre...
Figure S1. Sensitivity analysis of the association between TN and CSS outcomes in RCC patients. (TIF...